Shanghai Fair Indonesia 202611—12 November 2026

Healthcare

Shanghai Haohai Medical Technology Development Co.,Ltd.

Shanghai Haohai Medical Technology Development Co., Ltd. (hereinafter referred to as Haohai Vision) is the eye health business segment of Shanghai Haohai Biological Technology Co., Ltd. ,the first biopharmaceutical company in China listed on both the SSE STAR Market and the Hong Kong Stock Exchange. Founded in 2007, Haohai Vision has 18 years of expertise across the full industry chain, from raw materials to R&D, production,and sales. Today, we rank as a globally leading producer of intraocular lenses (IOLs), holding a prominent market share in China with annual sales exceeding 1 million units. In addition, our ophthalmic viscosurgical device (OVD) has maintained the No. 1 position in the Chinese market for 18 consecutive years. With a global perspective, we advance intelligent manufacturing in China. Supported by 7 R&D bases across 3 continents, we are committed to the efficient translation and localization of advanced technologies, enabling us to provide comprehensive eye health solutions accessible to patients worldwide throughout the full life cycle. Haohai Vision is shaping a new future of eye health, unlocking infinite possibilities for an extraordinary visual world.

Products & highlights

FVR IOL

  1. Patented Fourier Harmonic Diffractive Technology Achieves nearly 100% light energy utilization at a 3.5 mm pupil diameter. 2. Five-Focus Full-Range Vision Design Provides high-quality vision across the full visual range, from distance to near. 3. P.U.R.E. Impurity Removal Technology Helps reduce postoperative inflammatory response by removing impurities. 4. Nanometer-Scale CNC Manufacturing Process A polishing-free process that reduces energy loss and optical interference. 5. 360° Anti-PCO ring design Features a 360-degree continuous ridge structure to help prevent posterior capsule opacification.

Medical Sodium Hyaluronate Gel

A cohesive OVD characterized by high viscoelasticity, providing effective anterior chamber maintenance and surgical support. It also demonstrates excellent adhesiveness and coating ability, and can be removed easily at the end of surgery.

Trifocal IOL and Trifocal Toric IOL

A complete solution for cataracts and astigmatism, suitable for a broader range of cataract patients with visual needs across all distances. The Weighted Phase Model (W.P.M.) design increases the utilization rate of light to 90%, ensuring a smooth defocus curve and high-definition vision across the full viewing range. V-Free precision filtering technology reduces visual disturbances. The long-term effect is stable and excellent, resulting in high patient satisfaction.

Simedice®Monofocal Toric IOL

Designed to replace the natural lens in patients with cataracts and astigmatism, while correcting corneal astigmatism. The 0.25D small step cylindrical diopter, combined with ultra-precision moulding technology, has less residual astigmatism and more accurate diopter;The improved C loop with large contact angle, combined with the frosted, brings outstanding rotational stability.

Eyesucom® Lubricant eye drops

Featuring 0.4% chitosan and 0.05% sodium hyaluronate as its key ingredients, this formula works together to create a powerful synergistic effect. Long-lasting hydration: Positively charged chitosan bonds with negatively charged mucins on the ocular surface, while at the same time, forming complex structures with sodium hyaluronate to lock in moisture for lasting hydration. Dual repair effects: Compared to hyaluronic acid, chitosan has a stronger ability to promote corneal epithelial repair; the two ingredients work culmunatively to provide a dual repair effects. Natural antibacterial protection: The positively charged chitosan can bind to the negatively charged surfaces of bacteria, exerting a natural antibacterial effect. Available in single-dose and preservative-free multi dose formulations.

← Back to directory